{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:04:07Z","timestamp":1758279847345},"reference-count":31,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5551\/jat.13052","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T22:42:50Z","timestamp":1344465770000},"page":"862-871","source":"Crossref","is-referenced-by-count":11,"title":["Apolipoprotein B-48 to Triglyceride Ratio Is a Novel and Useful Marker for Detection of Type III Hyperlipidemia after Antihyperlipidemic Intervention"],"prefix":"10.5551","volume":"19","author":[{"given":"Miyako","family":"Yuasa-Kawase","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Kitazume-Taneike","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Nakaoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Tsubakio-Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Ohama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."},{"name":"Health Care Center, Osaka University."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Toyama-Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."},{"name":"Division of Health Sciences, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."},{"name":"Health Care Center, Osaka University."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Ishigami","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."},{"name":"Division of Health Sciences, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ohu University and Department of Internal Medicine, Ohu University Hospital."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Eto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ohu University and Department of Internal Medicine, Ohu University Hospital."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Matsuyama","sequence":"additional","affiliation":[{"name":"Department of Somatic Stem Cell Therapy, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ishigami M, Yamashita S, Sakai N, Hirano K, Hiraoka H, Nakamura T, Matsuzawa Y: Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins. Atherosclerosis, 2003; 168: 359-366","DOI":"10.1016\/S0021-9150(03)00136-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Fujioka Y, Ishikawa Y: Remnant lipoprotein as strong key particles to atherogenesis. J Atheroscler Thromb, 2009; 16: 145-154","DOI":"10.5551\/jat.E598"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hodis HN: Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation, 1999; 99: 2852-2854","DOI":"10.1161\/01.CIR.99.22.2852"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H: Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation, 1999; 99: 2858-2860","DOI":"10.1161\/01.CIR.99.22.2858"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nakada Y, Kurosawa H, Tohyama J, Inoue Y, Ikewaki K: Increased remnant lipoprotein in patients with coronary artery disease; evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogenous assay (RemL-C). J Atheroscler Thromb, 2007; 14: 56-64","DOI":"10.5551\/jat.14.56"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Davignon, J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis, 1988; 8: 1-21","DOI":"10.1161\/01.ATV.8.1.1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hopkins PN, Wu LL, Hunt SC, Brinton EA: Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol, 2005; 45: 1003-1012","DOI":"10.1016\/j.jacc.2004.11.062"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Mahley RW, Huang Y, Rall SC Jr: Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res, 1999; 40: 1933-1949","DOI":"10.1016\/S0022-2275(20)32417-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Brewer HB Jr, Zech LA, Gregg RE, Schwartz D, Schaefer EJ: NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med, 1983; 98(5 Pt 1): 623-640","DOI":"10.7326\/0003-4819-98-5-623"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, Brewer HB Jr: Familial apolipoprotein E deficiency. J Clin Invest, 1986; 78: 1206-1219","DOI":"10.1172\/JCI112704"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Morganroth J, Levy RI, Fredrickson DS: The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Intern Med, 1975; 82: 158-174","DOI":"10.7326\/0003-4819-82-2-158"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Marz W, Feussner G, Siekmeier R, Donnerhak B, Schaaf L, Ruzicka V, Gros W: Apolipoprotein E to B ratio: A marker for type III hyperlipoproteinemia. Eur J Clin Chem Clin Biochem, 1993; 31: 743-747","DOI":"10.1515\/cclm.1993.31.11.743"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Blom DJ, O' Neill FH, Marais AD: Screening for dysbetalipoproteinemia by plasma cholesterol and apolipoprotein B concentrations. Clin Chem, 2005; 51: 904-907","DOI":"10.1373\/clinchem.2004.047001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Sniderman A, Tremblay A, Bergeron J, Gagne C, Couture P: Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B. J Clin Lipidol, 2007; 1: 256-263","DOI":"10.1016\/j.jacl.2007.07.006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Murase T, Okubo M, Takeuchi I: Non-HDL-cholesterol\/ apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia. J Clin Lipidol, 2010; 4: 99-104","DOI":"10.1016\/j.jacl.2010.01.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Todo Y, Kobayashi J, Higashikata T, Kawashiri M, Nohara A, Inazu A, Koizumi J, Mabuchi H: Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2\/2 phenotype. Clin Chim Acta, 2004; 348: 35-40","DOI":"10.1016\/j.cccn.2004.04.018"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sakai N, Uchida Y, Ohashi K, Hibuse T, Saika Y, Tomari Y, Kihara S, Hiraoka H, Nakamura T, Ito S, Yamashita S, Matsuzawa Y: Measurement of fasting serum apo B-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J Lipid Res, 2003; 44: 1256-1262","DOI":"10.1194\/jlr.M300090-JLR200"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hanada H, Mugii S, Okubo M, Maeda I, Kuwayama K, Hidaka Y, Kitazume-Taneike R, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Yuasa-Kawase M, Nakatani K, Tsubakio-Yamamoto K, Masuda D, Ohama T, Matsuyama A, Ishigami M, Nishida M, Komuro I, Yamashita S: Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism. Clin Chim Acta, 2012; 413: 160-165","DOI":"10.1016\/j.cca.2011.09.013"},{"key":"19","unstructured":"19) Masuda D, Sakai N, Sugimoto T, Kitazume-Taneike R, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Nakatani K, Yuasa-Kawase M, Tsubakio-Yamamoto K, Ohama T, Nishida M, Ishigami M, Masuda Y, Matsuyama A, Komuro I, Yamashita S: Fasting serum apolipoprotein B-48 level can be a marker of postprandial hyperlipidemia. J Atheroscler Thromb, epub ahead of print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kinoshita M, Ohnishi H, Maeda T, Yoshimura N, Takeoka Y, Yasuda D, Kusano J, Mashimo Y, Saito S, Shimamoto K, Teramoto T: Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome. J Atheroscler Thromb, 2009; 16: 517-522","DOI":"10.5551\/jat.No604"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nakatani K, Sugimoto T, Masuda D, Okano R, Oya T, Monden Y, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Yuasa-Kawase M, Tsubakio-Yamamoto K, Ohama T, Nishida M, Ishigami M, Komuro I and Yamashita S: Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels. Atherosclerosis, 2011: 218; 226- 232","DOI":"10.1016\/j.atherosclerosis.2011.05.009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Tanimura K, Nakajima Y, Nagao M, Ishizaki A, Kano T, Harada T, Okajima F, Sudo M, Tamura H, Ishii S, Sugihara H, Yamashita S, Asai A, Oikawa S: Association of serum apolipoprotein B48 level with the presence of carotid plaque in type 2 diabetes mellitus. Diabetes Res Clin Pract, 2008; 81: 338-344","DOI":"10.1016\/j.diabres.2008.04.028"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Meyer E, Westerveld HT, de Ruyter-Meijstek FC, van Greevenbroek MM, Rienks R, van Rijn HJ, Erkelens DW, de Bruin TWA: Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Atherosclerosis, 1996; 124: 221-235","DOI":"10.1016\/0021-9150(96)05832-7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M: Japan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of Atherosclerosis. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb, 2007; 14: 155-158","DOI":"10.5551\/jat.E537"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Eto M, Nakata M, Iwashima Y, Watanabe K, Ikoda A, Kaka K: Type III hyperlipoproteinemia with apolipoprotein E2\/2 genotype in Japan. Clin Genet, 2002; 61: 416-422","DOI":"10.1034\/j.1399-0004.2002.610604.x"},{"key":"26","unstructured":"26) Weidman SW, Suarez B, Falko JM, Witztum JL, Kolar J, Raben M, Schonfeld G: Type III hyperlipoproteinemia: development of a VLDL apoE gel isoelectric focusing technique and application in family studies. J Lab Clin Med, 1979; 93: 549-569"},{"key":"27","unstructured":"27) Schmidt H, Mehring S, McMillan J: Interpreting the declaration of Helsinki (2008): “must”, “should” and different kinds of obligation. Med Law, 2010, 29: 565-591"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ooi EM, Watts GF, Chan DC, Chen MM, Nestel PJ, Sviridov D, Barrett PH: Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome. Diabetes Care, 2008; 31: 1656-1661","DOI":"10.2337\/dc08-0358"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Chan DC, Watts GF, Ooi EM, Ji J, Johnson AG, Barrett PH: Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome. Arterioscler Thromb Vasc Biol, 2008; 28: 1831-1837","DOI":"10.1161\/ATVBAHA.108.170530"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Masuda D, Nakagawa-Toyama Y, Nakatani K, Inagaki M, Tsubakio-Yamamoto K, Sandoval JC, Ohama T, Nishida M, Ishigami M, Yamashita S: Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia. Euro J Clin Invest, 2009; 39: 689-698","DOI":"10.1111\/j.1365-2362.2009.02163.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sandoval JC, Nakagawa-Toyama Y, Masuda D, Tochino Y, Nakaoka H, Kawase R, Yuasa-Kawase M, Nakatani K, Inagaki M, Tsubakio-Yamamoto K, Ohama T, Matsuyama A, Nishida M, Ishigami M, Komuro I, Yamashita S: Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia. J Atheroscler Thromb, 2010; 17: 914-924","DOI":"10.5551\/jat.4929"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/19\/9\/19_13052\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:41:29Z","timestamp":1643157689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/19\/9\/19_13052\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.13052","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}